JENNIFER MCKEOWN: Open Payments
NPI 1649914151 · IRMO, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,595 in 93 payments from 19 companies in 2025. Trend: 2023 $1,042 · 2024 $1,562 · 2025 $1,595
Food & beverage: $1,595
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $229 |
| Novo Nordisk Inc | 10 | $187 |
| AstraZeneca Pharmaceuticals LP | 10 | $165 |
| Corcept Therapeutics | 9 | $136 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| Dexcom, Inc. | 3 | $113 |
| Abbott Laboratories | 7 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| Recor Medical Inc | 3 | $69 |
Products named: Korlym, REXULTI, Dexcom G6 Transmitter, VRAYLAR, Wegovy, Kerendia, UBRELVY, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
